Interview with Karl Nikitsch, Menarini Austria
Dr. Nikitsch, you started Menarini’s Austrian operations almost 13 years ago. Would you say that Menarini’s presence in Austria today reflects the vision you had for the company in Austria…
Address: ‘Kölblgasse 8-10
1030 Wien ‘
,Austria
Tel: 01/711 78-0
Lilly makes medicines that help people live longer, healthier, more active lives.
We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. We have steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs.
Lilly is consistently ranked as one of the best companies in the world to work for, and generations of Lilly employees have sustained a culture that values excellence, integrity and respect for people.
The Austrian subsidiary of Eli Lilly was founded in June 1976. In total, nearly 190 employees are working in different sectors in Vienna. Vienna is a central hub and platform for international research activities; around 50 people are working in the Regional Medical Center.
Lilly Bio-Medicines
Lilly Bio-Medicines comprise the largest of Lilly’s five business areas in terms of sales, and account for nearly half of Lilly’s mid-to-late stage pipeline assets. This business unit is unique in that it focuses on multiple therapeutic areas.
Lilly Diabetes
Lilly Diabetes remains committed to meeting the needs of people with diabetes from medicines to support programs, including investments in one of our largest diabetes’ pipelines ever.
Elanco Animal Health
A global division of Lilly, Elanco works to develop and market products that improve animal health and protein production in more than 75 countries across the globe.
Lilly Oncology
As one of the top 10 oncology companies in the world, Lilly Oncology focuses on speeding innovation and improving outcomes for individual patients, and boasts one of the largest clinical pipelines in the oncology industry.
Dr. Nikitsch, you started Menarini’s Austrian operations almost 13 years ago. Would you say that Menarini’s presence in Austria today reflects the vision you had for the company in Austria…
Can you give our readers a snapshot of Austroplant’s scope of activities and its structure in Austria and the central European market? Austroplant/Dr Peithner belongs to the Schwabe Group, the…
Dr Prchla, you have been heading Merck’s Austrian subsidiary over the past eighteen months. What do you see as the key strengths of your company today? Mirroring the company’s structure,…
Just like other European countries, Austria is in the search for meaningful savings in healthcare. Austria’s increasingly price sensitive pharma market is seeing the rise of generic medicines gaining market…
Whereas most General Managers are exposed to different countries during their professional career, you have chosen to dedicate yours to the Austrian market. What is it in this country so…
You have been General Secretary of PHARMIG since 2004 and have witnessed the market’s development over the past 8 years. What have been the most important changes since you started…
See our Cookie Privacy Policy Here
